Talquetamab with Iberdomide
A Phase Ib, Multi-center, Study of Talquetamab in Combination With Iberdomide and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
More Information
- Trial Status
- Not yet accepting
- Trial Phase
- Phase 1
- Enrollment
- 38 patients (estimated)
- Sponsors
- University of California San Francisco
- Collaborators
- Bristol Myers Squibb, Janssen Research & Development LLC, Bristol Myers Squibb, Janssen Research & Development LLC
- Tags
- Bispecific Antibody, CD3, GPRC5D
- Trial Type
- Treatment
- Last Update
- 2 weeks ago
- SparkCures ID
- 1877
- NCT Identifier
- NCT06348108
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.